T/CACM 1249-2019 Active Group standards

T/CACM 1249-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Drug-induced Liver Injury

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1249-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Integrated services in the fields of medicine, health, and labor protection

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline proposes recommendations for the diagnosis, differentiation, treatment, prevention, and care of drug-induced liver damage. This guideline is applicable to the diagnosis and prevention of drug-induced liver damage in people aged 18 and above. This guideline is suitable for clinicians in relevant departments such as the Department of Traditional Chinese Medicine in general hospitals, the Department of Spleen, Stomach, Liver and Gallbladder in traditional Chinese hospitals, and grassroots-level traditional Chinese doctors.